Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Hematologic Neoplasms × monalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lung Neoplasms 1 Hematologic Neoplasms 1

Interventions

Cyclophosphamide 17 fludarabine 15 fludarabine phosphate 11 Azacitidine 8 venetoclax 7 Rituximab 7 Nivolumab 7 Tacrolimus 6 Melphalan 6 Cytarabine 6 Specimen Handling 5 Sirolimus 5 Clofarabine 5 belinostat 4 aldesleukin 4 Thiotepa 4 Standard of Care 4 Practice Guidelines as Topic 4 Mycophenolic Acid 4 Methotrexate 4 Ipilimumab 4 Granulocyte Colony-Stimulating Factor 4 CTLA-4 Antigen 4 Bevacizumab 4 Antilymphocyte Serum 4 AP 1903 reagent 4 thymoglobulin 3 ibrutinib 3 Whole-Body Irradiation 3 Oxaliplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02921685 2018-09-19

PIRAT

Institut Paoli-Calmettes

Phase 1 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡